Preparing for a peptide conversation with a clinician
A neutral question list for discussing goals, evidence, product status, and uncertainty.
Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
Bring a complete medication and supplement list, relevant diagnoses, allergies, and the exact product information behind your question. Ask about regulatory status, evidence for your situation, important uncertainties, interactions, warning signs, alternatives, and follow-up. Do not stop or start a medicine based on educational content alone.
Related resources
Continue with curated, same-topic resources from the published library. These links are educational references, not treatment recommendations.
An adverse-event report is a safety signal, not proof of cause
How to read safety reporting responsibly—and why suspected problems should still be taken seriously.
Open resourceArticleEpithalon: telomere research and claim boundaries
A guide to epithalamin/epithalon aging research without turning telomere biology into a longevity promise.
Open resourceArticleThymosin alpha-1: immune-modulation research
How to evaluate immune-peptide claims while keeping research interest separate from clinical recommendations.
Open resourceArticleSS-31 (elamipretide): mitochondrial peptide research
Understanding SS-31 as an active mitochondrial-targeting research program—not a shortcut to an energy or aging claim.
Open resourceArticleNAD+ precursors and injections: research vs. product claims
A framework for reading NAD+ biology, precursor studies, and injectable product marketing side by side.
Open resource